INFI Annual D&A
$458.00 K
-$22.00 K-4.58%
31 December 2022
Summary:
As of January 21, 2025, INFI annual depreciation & amortization is $458.00 thousand, with the most recent change of -$22.00 thousand (-4.58%) on December 31, 2022. During the last 3 years, it has risen by +$239.00 thousand (+109.13%).INFI Depreciation And Amortization Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
INFI Quarterly D&A
$106.00 K
+$1000.00+0.95%
30 June 2023
Summary:
As of January 21, 2025, INFI quarterly depreciation & amortization is $106.00 thousand, with the most recent change of +$1000.00 (+0.95%) on June 30, 2023. Over the past year, it has dropped by -$14.00 thousand (-11.67%).INFI Quarterly D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
INFI TTM D&A
$428.00 K
-$14.00 K-3.17%
30 June 2023
Summary:
As of January 21, 2025, INFI TTM depreciation & amortization is $428.00 thousand, with the most recent change of -$14.00 thousand (-3.17%) on June 30, 2023. Over the past year, it has dropped by -$54.00 thousand (-11.20%).INFI TTM D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
INFI Depreciation And Amortization Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -4.6% | -11.7% | -11.2% |
| 3 y3 years | +109.1% | -13.1% | -3.4% |
| 5 y5 years | -73.3% | +100.0% | +95.4% |
INFI Depreciation And Amortization High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | ||||||
| 5 y | 5-year | ||||||
| alltime | all time | -99.2% | -99.8% | -99.2% |
Infinity Pharmaceuticals Depreciation And Amortization History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| June 2023 | - | $106.00 K(+1.0%) | $428.00 K(-3.2%) |
| Mar 2023 | - | $105.00 K(-0.9%) | $442.00 K(-3.5%) |
| Dec 2022 | $458.00 K(-4.6%) | $106.00 K(-4.5%) | $458.00 K(-3.0%) |
| Sept 2022 | - | $111.00 K(-7.5%) | $472.00 K(-2.1%) |
| June 2022 | - | $120.00 K(-0.8%) | $482.00 K(0.0%) |
| Mar 2022 | - | $121.00 K(+0.8%) | $482.00 K(+0.4%) |
| Dec 2021 | $480.00 K(-0.6%) | $120.00 K(-0.8%) | $480.00 K(+0.2%) |
| Sept 2021 | - | $121.00 K(+0.8%) | $479.00 K(-0.2%) |
| June 2021 | - | $120.00 K(+0.8%) | $480.00 K(-0.4%) |
| Mar 2021 | - | $119.00 K(0.0%) | $482.00 K(-0.2%) |
| Dec 2020 | $483.00 K(+120.5%) | $119.00 K(-2.5%) | $483.00 K(-3.6%) |
| Sept 2020 | - | $122.00 K(0.0%) | $501.00 K(+13.1%) |
| June 2020 | - | $122.00 K(+1.7%) | $443.00 K(+34.7%) |
| Mar 2020 | - | $120.00 K(-12.4%) | $329.00 K(+50.2%) |
| Dec 2019 | $219.00 K(+14.7%) | $137.00 K(+114.1%) | $219.00 K(+95.5%) |
| Sept 2019 | - | $64.00 K(+700.0%) | $112.00 K(+20.4%) |
| June 2019 | - | $8000.00(-20.0%) | $93.00 K(-32.6%) |
| Mar 2019 | - | $10.00 K(-66.7%) | $138.00 K(-27.7%) |
| Dec 2018 | $191.00 K(-88.9%) | $30.00 K(-33.3%) | $191.00 K(-17.3%) |
| Sept 2018 | - | $45.00 K(-15.1%) | $231.00 K(-48.3%) |
| June 2018 | - | $53.00 K(-15.9%) | $447.00 K(-58.8%) |
| Mar 2018 | - | $63.00 K(-10.0%) | $1.09 M(-36.7%) |
| Dec 2017 | $1.72 M(-49.8%) | $70.00 K(-73.2%) | $1.72 M(-31.3%) |
| Sept 2017 | - | $261.00 K(-62.3%) | $2.50 M(-26.9%) |
| June 2017 | - | $692.00 K(0.0%) | $3.42 M(-0.0%) |
| Mar 2017 | - | $692.00 K(-18.8%) | $3.42 M(-0.0%) |
| Dec 2016 | $3.42 M(+49.1%) | $852.00 K(-27.8%) | $3.42 M(+3.5%) |
| Sept 2016 | - | $1.18 M(+70.3%) | $3.30 M(+21.8%) |
| June 2016 | - | $693.00 K(0.0%) | $2.71 M(+3.0%) |
| Mar 2016 | - | $693.00 K(-5.7%) | $2.63 M(+14.8%) |
| Dec 2015 | $2.29 M(+29.3%) | $735.00 K(+24.8%) | $2.29 M(+16.8%) |
| Sept 2015 | - | $589.00 K(-4.1%) | $1.96 M(+7.8%) |
| June 2015 | - | $614.00 K(+73.4%) | $1.82 M(+9.8%) |
| Mar 2015 | - | $354.00 K(-12.8%) | $1.66 M(-6.4%) |
| Dec 2014 | $1.77 M(-2.7%) | $406.00 K(-9.2%) | $1.77 M(-4.4%) |
| Sept 2014 | - | $447.00 K(-1.1%) | $1.85 M(-1.0%) |
| June 2014 | - | $452.00 K(-3.4%) | $1.87 M(+1.2%) |
| Mar 2014 | - | $468.00 K(-3.9%) | $1.85 M(+1.4%) |
| Dec 2013 | $1.82 M(+11.0%) | $487.00 K(+4.7%) | $1.82 M(+5.9%) |
| Sept 2013 | - | $465.00 K(+8.4%) | $1.72 M(+3.7%) |
| June 2013 | - | $429.00 K(-2.9%) | $1.66 M(+1.3%) |
| Mar 2013 | - | $442.00 K(+14.5%) | $1.64 M(-0.2%) |
| Dec 2012 | $1.64 M(-21.7%) | $386.00 K(-4.5%) | $1.64 M(-4.6%) |
| Sept 2012 | - | $404.00 K(-0.7%) | $1.72 M(-3.7%) |
| June 2012 | - | $407.00 K(-8.7%) | $1.79 M(-9.0%) |
| Mar 2012 | - | $446.00 K(-4.3%) | $1.97 M(-6.3%) |
| Dec 2011 | $2.10 M | $466.00 K(-1.1%) | $2.10 M(-3.8%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2011 | - | $471.00 K(-19.3%) | $2.18 M(-3.8%) |
| June 2011 | - | $584.00 K(+1.0%) | $2.27 M(+2.8%) |
| Mar 2011 | - | $578.00 K(+5.1%) | $2.21 M(+1.0%) |
| Dec 2010 | $2.18 M(+1.4%) | $549.80 K(-1.2%) | $2.18 M(-0.6%) |
| Sept 2010 | - | $556.20 K(+6.6%) | $2.20 M(-0.4%) |
| June 2010 | - | $521.70 K(-6.2%) | $2.21 M(-0.4%) |
| Mar 2010 | - | $556.30 K(-1.1%) | $2.22 M(+2.8%) |
| Dec 2009 | $2.15 M(+9.2%) | $562.60 K(-0.4%) | $2.15 M(+5.4%) |
| Sept 2009 | - | $564.80 K(+6.3%) | $2.04 M(+4.2%) |
| June 2009 | - | $531.50 K(+7.4%) | $1.96 M(+1.8%) |
| Mar 2009 | - | $495.00 K(+9.5%) | $1.93 M(-2.3%) |
| Dec 2008 | $1.97 M(-29.8%) | $451.90 K(-6.4%) | $1.97 M(-8.2%) |
| Sept 2008 | - | $482.80 K(-2.8%) | $2.15 M(-10.9%) |
| June 2008 | - | $496.60 K(-8.2%) | $2.41 M(-8.6%) |
| Mar 2008 | - | $540.70 K(-13.9%) | $2.64 M(-6.0%) |
| Dec 2007 | $2.81 M(-23.9%) | $628.20 K(-15.8%) | $2.81 M(-9.1%) |
| Sept 2007 | - | $745.90 K(+2.9%) | $3.09 M(-8.1%) |
| June 2007 | - | $724.90 K(+2.3%) | $3.36 M(-4.0%) |
| Mar 2007 | - | $708.40 K(-22.0%) | $3.50 M(-5.0%) |
| Dec 2006 | $3.69 M(-4.7%) | $908.00 K(-10.9%) | $3.69 M(+3.3%) |
| Sept 2006 | - | $1.02 M(+17.8%) | $3.57 M(-36.6%) |
| June 2006 | - | $865.40 K(-3.2%) | $5.63 M(+63.1%) |
| Mar 2006 | - | $893.80 K(+12.9%) | $3.45 M(-10.8%) |
| Dec 2005 | $3.87 M(+0.1%) | $791.50 K(-74.3%) | $3.87 M(+74.8%) |
| Sept 2005 | - | $3.08 M(-334.4%) | $2.21 M(+188.4%) |
| June 2005 | - | -$1.31 M(-200.0%) | $767.60 K(-78.9%) |
| Mar 2005 | - | $1.31 M(-252.0%) | $3.64 M(-5.8%) |
| Dec 2004 | $3.87 M(-31.8%) | -$863.90 K(-153.0%) | $3.87 M(-39.4%) |
| Sept 2004 | - | $1.63 M(+4.4%) | $6.38 M(+1.1%) |
| June 2004 | - | $1.56 M(+1.7%) | $6.31 M(+8.7%) |
| Mar 2004 | - | $1.54 M(-6.8%) | $5.81 M(+2.5%) |
| Dec 2003 | $5.67 M(-90.1%) | $1.65 M(+5.5%) | $5.67 M(-90.0%) |
| Sept 2003 | - | $1.56 M(+47.7%) | $56.70 M(+0.4%) |
| June 2003 | - | $1.06 M(-24.1%) | $56.45 M(-1.0%) |
| Mar 2003 | - | $1.40 M(-97.4%) | $57.00 M(-0.1%) |
| Dec 2002 | $57.04 M(+352.8%) | $52.68 M(+3910.3%) | $57.04 M(+663.6%) |
| Sept 2002 | - | $1.31 M(-18.5%) | $7.47 M(-19.4%) |
| June 2002 | - | $1.61 M(+12.7%) | $9.27 M(-15.6%) |
| Mar 2002 | - | $1.43 M(-54.0%) | $10.98 M(-12.8%) |
| Dec 2001 | $12.60 M(-4.6%) | $3.11 M(-0.0%) | $12.60 M(-26.8%) |
| Sept 2001 | - | $3.11 M(-6.3%) | $17.21 M(+3.0%) |
| June 2001 | - | $3.32 M(+9.2%) | $16.71 M(+8.7%) |
| Mar 2001 | - | $3.04 M(-60.6%) | $15.37 M(+16.5%) |
| Dec 2000 | $13.20 M(+1865.4%) | $7.73 M(+195.4%) | $13.20 M(+141.2%) |
| Sept 2000 | - | $2.62 M(+31.8%) | $5.47 M(+91.6%) |
| June 2000 | - | $1.99 M(+127.8%) | $2.86 M(+227.8%) |
| Mar 2000 | - | $871.50 K | $871.50 K |
| Dec 1999 | $671.70 K | - | - |
FAQ
- What is Infinity Pharmaceuticals annual depreciation & amortization?
- What is the all time high annual D&A for Infinity Pharmaceuticals?
- What is Infinity Pharmaceuticals annual D&A year-on-year change?
- What is Infinity Pharmaceuticals quarterly depreciation & amortization?
- What is the all time high quarterly D&A for Infinity Pharmaceuticals?
- What is Infinity Pharmaceuticals quarterly D&A year-on-year change?
- What is Infinity Pharmaceuticals TTM depreciation & amortization?
- What is the all time high TTM D&A for Infinity Pharmaceuticals?
- What is Infinity Pharmaceuticals TTM D&A year-on-year change?
What is Infinity Pharmaceuticals annual depreciation & amortization?
The current annual D&A of INFI is $458.00 K
What is the all time high annual D&A for Infinity Pharmaceuticals?
Infinity Pharmaceuticals all-time high annual depreciation & amortization is $57.04 M
What is Infinity Pharmaceuticals annual D&A year-on-year change?
Over the past year, INFI annual depreciation & amortization has changed by -$22.00 K (-4.58%)
What is Infinity Pharmaceuticals quarterly depreciation & amortization?
The current quarterly D&A of INFI is $106.00 K
What is the all time high quarterly D&A for Infinity Pharmaceuticals?
Infinity Pharmaceuticals all-time high quarterly depreciation & amortization is $52.68 M
What is Infinity Pharmaceuticals quarterly D&A year-on-year change?
Over the past year, INFI quarterly depreciation & amortization has changed by -$14.00 K (-11.67%)
What is Infinity Pharmaceuticals TTM depreciation & amortization?
The current TTM D&A of INFI is $428.00 K
What is the all time high TTM D&A for Infinity Pharmaceuticals?
Infinity Pharmaceuticals all-time high TTM depreciation & amortization is $57.04 M
What is Infinity Pharmaceuticals TTM D&A year-on-year change?
Over the past year, INFI TTM depreciation & amortization has changed by -$54.00 K (-11.20%)